Expression of Osteopontin and Gremlin 1 Proteins in Cardiomyocytes in Ischemic Heart Failure

• Published in: International journal of molecular sciences Vol. 25; no. 15; p. 8240
• Main Authors: Kuprytė, Milda, Lesauskaitė, Vaiva, Siratavičiūtė, Vitalija, Utkienė, Lina, Jusienė, Lina, Pangonytė, Dalia
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.08.2024
• Subjects: Aged; cardiomyocyte remodeling; Cardiomyocytes; Development and progression; Female; gremlin 1; Heart cells; Heart failure; Heart Failure - metabolism; Heart Failure - pathology; Humans; immunohistochemistry; Intercellular Signaling Peptides and Proteins - genetics; Intercellular Signaling Peptides and Proteins - metabolism; Ischemia; ischemic heart failure; Male; Medical research; Medicine, Experimental; Middle Aged; Myocardial Ischemia - metabolism; Myocardial Ischemia - pathology; Myocytes, Cardiac - metabolism; Myocytes, Cardiac - pathology; osteopontin; Osteopontin - genetics; Osteopontin - metabolism; Pathogenesis; Protein expression; Proteins; Trends; gremlin 1; cardiomyocyte remodeling; immunohistochemistry; ischemic heart failure; osteopontin
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms25158240

A relevant role of osteopontin (OPN) and gremlin 1 (Grem1) in regulating cardiac tissue remodeling and formation of heart failure (HF) are documented, with the changes of OPN and Grem1 levels in blood plasma due to acute ischemia, ischemic heart disease-induced advanced HF or dilatative cardiomyopathy being the primary focus in most of these studies. However, knowledge on the early OPN and Grem1 proteins expression changes within cardiomyocytes during remodeling due to chronic ischemia remains insufficient. The aim of this study was to determine the OPN and Grem1 proteins expression changes in human cardiomyocytes at different stages of ischemic HF. A semi-quantitative immunohistochemical analysis was performed in 105 myocardial tissue samples obtained from the left cardiac ventricles. Increased OPN immunostaining intensity was already detected in the stage A HF group, compared to the control group ( < 0.001), and continued to increase in the stage B HF ( < 0.001), achieving the peak of immunostaining in the stages C/D HF group ( < 0.001). Similar data of Grem1 immunostaining intensity changes in cardiomyocytes were documented. Significantly positive correlations were detected between OPN, Grem1 expression in cardiomyocytes and their diameter as well as the length, in addition to positive correlation between OPN and Grem1 expression changes within cardiomyocytes. These novel findings suggest that OPN and Grem1 contribute significantly to reorganization of cellular geometry from the earliest stage of cardiomyocyte remodeling, providing new insights into the ischemic HF pathogenesis.